CCL5 and breast cancer: In a model of mammary tumor engraftment by tumor cells with a conditional Her2 downmodulation inducible by doxycycline which leads to tumor regression, the following tumoral recurrence is associated with an increased tumor production of CCL5, a chemokine involved in many aspects of tumor progression in breast cancer (76).